Share
Inside the Complexity of LNP Formulation
Understand the Science Behind Effective Lipid Nanoparticle Delivery
Lipid nanoparticles (LNPs) have become a leading nonviral delivery system for nucleic acid therapeutics, but developing an effective LNP formulation requires balancing many interconnected factors. Lipid composition, particle properties, endosomal escape, biodistribution, targeting, stability, and tolerability can all influence therapeutic performance.
In this thought leadership article, experts from Phosphorex and NOF Corporation examine the mechanisms that drive LNP performance and the formulation strategies used to support successful oligonucleotide delivery.
In This Article, You’ll Learn:
How helper lipids, PEG lipids, cholesterol, and ionizable lipids contribute to LNP performance
How LNPs protect nucleic acid payloads and enable cellular uptake and endosomal release
Key differences between passive and active targeting strategies
How lipid selection, particle size, surface properties, and component ratios affect biodistribution and tolerability
Why a staged development strategy can help optimize LNP formulations and reduce program risk
How proprietary ionizable lipids and advanced screening approaches can support formulation development
Download the article to explore the science, trade-offs, and development strategies behind effective lipid nanoparticle formulations.